Our results demonstrate that CSNK1D has a good prognostic evaluation effect in hepatocellular carcinoma, with an AUC of 0.719, 0.624, and 0.618 for 1-year, 3-year, and 5-year survival rates, respectively (Figure 8I). Here, CSNK1D is linked to hepatocellular carcinoma.